foxo4 dri senolytic 2023 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis Contains:10 sterile vials x 238 mg/0.0084 oz. Muscle bpc-157 oral bioavailability studies
SKU: 33824601169
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11



















